Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 950 of 2051 entries
View as:

A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)

Phase: N/A Priority: Normal
NCT ID: NCT00506389 Org: User:
Start: 06/06/07 End: 02/13/08 Due: 02/13/09

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)

Phase: N/A Priority: Normal
NCT ID: NCT02698189 Org: User:
Start: 05/19/16 End: 09/09/21 Due: 09/09/22

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Phase: N/A Priority: Normal
NCT ID: NCT00686699 Org: User:
Start: 07/10/06 End: 03/06/08 Due: 03/06/09

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

Phase: N/A Priority: Normal
NCT ID: NCT00535236 Org: User:
Start: 11/02/07 End: 01/26/10 Due: 01/26/11

A Study in Subjects With Retinal Detachment

Phase: N/A Priority: Normal
NCT ID: NCT00210067 Org: User:
Start: 05/31/01 End: 06/30/02 Due: 06/30/03

Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00106626 Org: User:
Start: 08/31/05 End: 12/31/07 Due: 12/31/08

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)

Phase: N/A Priority: Normal
NCT ID: NCT02059174 Org: User:
Start: 02/10/14 End: 04/27/15 Due: 04/27/16

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Phase: N/A Priority: Normal
NCT ID: NCT00545584 Org: User:
Start: 04/01/07 End: 11/19/09 Due: 11/19/10

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)

Phase: N/A Priority: Normal
NCT ID: NCT01624974 Org: User:
Start: 08/09/12 End: 05/05/14 Due: 05/05/15

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

Phase: N/A Priority: Normal
NCT ID: NCT01295632 Org: User:
Start: 02/28/11 End: 08/31/15 Due: 08/31/16

Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773)

Phase: N/A Priority: Normal
NCT ID: NCT00656799 Org: User:
Start: 04/30/08 End: 07/31/09 Due: 07/31/10

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

Phase: N/A Priority: Normal
NCT ID: NCT00875394 Org: User:
Start: 02/01/07 End: 06/27/08 Due: 06/27/09

The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00872001 Org: User:
Start: 04/30/09 End: 10/31/10 Due: 10/31/11

A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).

Phase: N/A Priority: Normal
NCT ID: NCT02033889 Org: User:
Start: 12/13/13 End: 08/03/17 Due: 08/03/18

[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)

Phase: N/A Priority: Normal
NCT ID: NCT02621606 Org: User:
Start: 01/08/16 End: 12/28/17 Due: 12/28/18

Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)

Phase: N/A Priority: Normal
NCT ID: NCT04193202 Org: User:
Start: 05/21/20 End: 11/03/21 Due: 11/03/22

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)

Phase: N/A Priority: Normal
NCT ID: NCT00443209 Org: User:
Start: 02/21/07 End: 01/22/09 Due: 01/22/10

Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

Phase: N/A Priority: Normal
NCT ID: NCT04776148 Org: User:
Start: 03/29/21 End: 09/27/24 Due: 09/27/25

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00274716 Org: User:
Start: 11/30/05 End: 01/31/07 Due: 01/31/08

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Phase: N/A Priority: Normal
NCT ID: NCT01814722 Org: User:
Start: 11/09/12 End: 10/31/13 Due: 10/31/14

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Phase: N/A Priority: Normal
NCT ID: NCT03893448 Org: User:
Start: 06/19/19 End: 05/24/21 Due: 05/24/22

Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)

Phase: N/A Priority: Normal
NCT ID: NCT02460198 Org: User:
Start: 08/25/15 End: 02/19/21 Due: 02/19/22

A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00132769 Org: User:
Start: 01/31/05 End: 11/30/05 Due: 11/30/06

Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164)

Phase: N/A Priority: Normal
NCT ID: NCT01979510 Org: User:
Start: 11/30/13 End: 05/31/14 Due: 05/31/15

A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)

Phase: N/A Priority: Normal
NCT ID: NCT03565068 Org: User:
Start: 06/20/18 End: 04/03/20 Due: 04/03/21